Moreover, after various neuroleptics, typical and atypical, peripherally acting domperidone, and amphetamine, BPC 157 therapy attenuated/eliminated as a general effect vascular and multiorgan failure, major vessel failure, thrombosis, advanced Virchow triad circumstances, and blood pressure disturbances (intracranial (superior sagittal sinus), caval and portal hypertension, and aortal hypotension) both peripherally and centrally [54]
Dose escalation phase (titration) After the first 4 weeks, if the medication is well tolerated, your healthcare provider will typically increase the dosage to 5 mg once weekly for the next 4 weeks (weeks 5-8)
A new 4 mg maintenance-dose arm is under investigation in the TRIUMPH program as a long-term post-titration dose
The peptide restored glucose metabolism markers including improved glucose disappearance rates and normalized insulin response peaks, suggesting restoration of pancreatic and metabolic function to more youthful states
